Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PinnacleXon Jul 19, 2019 9:23pm
57 Views
Post# 29942147

RE:RE:RE:RE:RE:RE:RE:2020

RE:RE:RE:RE:RE:RE:RE:2020
palinc2000 wrote:




scarlet1967 wrote: We on this board all know about the potential of this company the problem is the general market seems to have no idea about all the future catalysts or don’t believe in them for that we should blame management just look at the response I got from Dubuc one has to read between lines to come to a conclusion what he was trying to say.
For years many on this board including myself have criticized the company’s communication behaviour, lack of clarity among other things and they know about it as they apparently monitoreas 40 this board yet no change on that front.
It is painful to see the sp drifting lower to now early stage of Trogarzo news.
There is a need of changes in running this business and that has to happen now more than ever as company are going back to nasdaq.
Hopefully they are working on it and are well prepared for the bigger audience by improving their communication skills.
 




Lol, potential in the stcok market, this really shows how little you know about the stock market.   


The bad case just happened today and we got that candle I mentioned earlier, well all we can do now is watch as this falls and how far who reallly knows, but 4.75 is very likley.  Moron of a CEO that has child like answers and discussions and its becoming apparent. 

Bullboard Posts